Pharsight
Ask Pharsight
LINDIS BIOTECH GMBH PATENTS FACING OPPOSITIONS
Top patents of LINDIS BIOTECH GMBH facing oppositions at the European Patent Office (EPO)
Activity Alert
Get e-mail alerts for changes to below patents
Patent Number
Grant Date
Patent Title
Expected Expiration Date
Facing Oppositions
Activity Alert
EP3177645B1
17 Feb, 2021
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer
Aug, 2035
10